Friday, May 9, 2014

FDA Meeting is This Tuesday!

If you registered for the Tuesday, May 13 meeting with the Food and Drug Administration (FDA), don’t forget to attend!

This is a rare and important opportunity for PAH patients and their loved ones to speak directly with FDA drug reviewers. The conversation will help FDA stay focused on patient needs when making decisions about the safety and effectiveness of new PH drugs.

Webcast: If you registered to participate by webcast, look for an email from FDA with log-in information.

In Person:
Tuesday, May 13; 1-5 p.m. ET
FDA Campus
10903 New Hampshire Avenue
Building 31, Great Room
Silver Spring, MD 20993

Additional information about the meeting is available as a 15-minute webinar or as a PDF. You can also contact Katie at or 301-565-3004 x749.